tradingkey.logo

Allurion Technologies Inc

ALUR
1.100USD
+0.030+2.80%
종가 02/06, 16:00ET시세는 15분 지연됩니다
8.54M시가총액
손실P/E TTM

Allurion Technologies Inc

1.100
+0.030+2.80%

자세한 내용은 Allurion Technologies Inc 회사

Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.

Allurion Technologies Inc 정보

종목 코드 ALUR
회사 이름Allurion Technologies Inc
상장일Mar 29, 2021
CEOGaur (Shantanu)
직원 수134
유형Ordinary Share
회계 연도 종료Mar 29
주소11 Huron Dr Ste 200
도시NATICK
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호01760
전화15086474000
웹사이트https://www.allurion.com/en
종목 코드 ALUR
상장일Mar 29, 2021
CEOGaur (Shantanu)

Allurion Technologies Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Dr. Shantanu Gaur, M.D.
Dr. Shantanu Gaur, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
62.03K
-16000.00%
Mr. Larson Douglas Hudson
Mr. Larson Douglas Hudson
Independent Director
Independent Director
1.21K
+604.00%
Dr. Omar Syed Ishrak, Ph.D.
Dr. Omar Syed Ishrak, Ph.D.
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
--
--
Dr. Ram Chuttani
Dr. Ram Chuttani
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Krishna K. Gupta
Mr. Krishna K. Gupta
Independent Director
Independent Director
--
--
Mr. Michael Davin
Mr. Michael Davin
Independent Director
Independent Director
--
--
Mr. Nicholas Sheridan (Nick) Lewin
Mr. Nicholas Sheridan (Nick) Lewin
Independent Director
Independent Director
--
--
Mr. Mike Cavanaugh
Mr. Mike Cavanaugh
Investor Relations
Investor Relations
--
--
Mr. Keith Johns
Mr. Keith Johns
Independent Director
Independent Director
--
--
Mr. R. Jason Richey
Mr. R. Jason Richey
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Shantanu Gaur, M.D.
Dr. Shantanu Gaur, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
62.03K
-16000.00%
Mr. Larson Douglas Hudson
Mr. Larson Douglas Hudson
Independent Director
Independent Director
1.21K
+604.00%
Dr. Omar Syed Ishrak, Ph.D.
Dr. Omar Syed Ishrak, Ph.D.
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
--
--
Dr. Ram Chuttani
Dr. Ram Chuttani
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Krishna K. Gupta
Mr. Krishna K. Gupta
Independent Director
Independent Director
--
--
Mr. Michael Davin
Mr. Michael Davin
Independent Director
Independent Director
--
--

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
기업이 아직 관련 데이터를 공개하지 않았습니다.
지역별USD
이름
수익
비율
All other countries
941.00K
35.40%
Egypt (Country)
450.00K
16.93%
Italy
418.00K
15.73%
Spain
282.00K
10.61%
Argentina
272.00K
10.23%
기타
295.00K
11.10%
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.

주식 보유 통계

마지막 업데이트: Sun, Feb 1
마지막 업데이트: Sun, Feb 1
주주
주주 유형
주주
주주
비율
RTW Investments L.P.
47.98%
Leavitt Equity Partners III LP
3.77%
Armistice Capital LLC
1.51%
Lunt Capital Management Inc
1.36%
Romulus Capital Management, LLC
1.33%
기타
44.06%
주주
주주
비율
RTW Investments L.P.
47.98%
Leavitt Equity Partners III LP
3.77%
Armistice Capital LLC
1.51%
Lunt Capital Management Inc
1.36%
Romulus Capital Management, LLC
1.33%
기타
44.06%
주주 유형
주주
비율
Investment Advisor/Hedge Fund
48.42%
Corporation
4.83%
Investment Advisor
3.06%
Hedge Fund
1.63%
Individual Investor
1.53%
Venture Capital
1.43%
기타
39.09%

기관 주식 보유

마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
68
6.53M
39.03%
+3.35M
2025Q3
70
3.18M
46.56%
+1.57K
2025Q2
85
3.18M
48.45%
-269.85K
2025Q1
86
1.95M
28.76%
+237.16K
2024Q4
84
752.22K
40.38%
-48.13K
2024Q3
168
830.35K
127.59%
-73.34K
2024Q2
179
581.38K
156.78%
+113.95K
2024Q1
186
467.42K
172.37%
-2.84M
2023Q4
188
468.03K
181.14%
+55.07K
2023Q3
189
413.41K
181.62%
-47.54K
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
RTW Investments L.P.
5.89M
63.6%
+3.35M
+131.71%
Nov 12, 2025
Leavitt Equity Partners III LP
462.76K
5%
+296.10K
+177.66%
Feb 19, 2025
Armistice Capital LLC
185.00K
2%
-206.64K
-52.76%
Jun 30, 2025
Romulus Capital Management, LLC
163.14K
1.76%
--
--
Oct 31, 2025
Compute Health Sponsor LLC
130.51K
1.41%
--
--
Oct 31, 2025
The Vanguard Group, Inc.
56.18K
0.61%
+6.82K
+13.81%
Sep 30, 2025
Gupta (Krishna K.)
76.18K
0.82%
+3.12K
+4.27%
Oct 31, 2025
Gaur (Shantanu)
62.03K
0.67%
-16.00K
-20.50%
Oct 31, 2025
Olayan Investments Company Establishment
49.70K
0.54%
--
--
Sep 30, 2025
더 보기

관련 ETF

마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
iShares Micro-Cap ETF
0%
Janus Henderson Small Cap Growth Alpha ETF
0%
iShares Micro-Cap ETF
비율0%
Janus Henderson Small Cap Growth Alpha ETF
비율0%

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
Dec 24, 2024
Merger
25→1
Dec 24, 2024
Merger
25→1
Dec 24, 2024
Merger
25→1
Dec 24, 2024
Merger
25→1
날짜
배당락일
유형
비율
Dec 24, 2024
Merger
25→1
Dec 24, 2024
Merger
25→1
Dec 24, 2024
Merger
25→1
Dec 24, 2024
Merger
25→1
KeyAI